Skip to content
10-Q

Quarterly Report

ZYVERSA THERAPEUTICS, INC. ZVSA

0001641172-25-023342

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 8.1M sh
Shares Diluted Q2 2025 · Jun 30, 2025 4.81M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 834.92K sh
Shares Diluted Q2 2025 · Jun 30, 2024 729.31K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.29M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$5.69M
Stockholders Equity Q2 2025 · Jun 30, 2025 $6.1M
Stockholders Equity Q2 2025 · Mar 31, 2025 $8.13M
Stockholders Equity Q2 2025 · Dec 31, 2024 $8.52M
Stockholders Equity Q2 2025 · Jun 30, 2024 $8.62M
Stockholders Equity Q2 2025 · Mar 31, 2024 $11.22M
Stockholders Equity Q2 2025 · Dec 31, 2023 $11.07M
Current Liabilities Q2 2025 · Jun 30, 2025 $12.69M
Current Liabilities Q2 2025 · Dec 31, 2024 $11.23M
Total Liabilities Q2 2025 · Jun 30, 2025 $13.54M
Total Liabilities Q2 2025 · Dec 31, 2024 $12.08M
Current Assets Q2 2025 · Jun 30, 2025 $549.07K
Current Assets Q2 2025 · Dec 31, 2024 $1.72M
Total Assets Q2 2025 · Jun 30, 2025 $19.64M
Total Assets Q2 2025 · Dec 31, 2024 $20.6M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$3.31
Eps Diluted Q2 2025 · Jun 30, 2024 −$7.67
Eps Basic Q2 2025 · Jun 30, 2025 −$0.46
Eps Basic Q2 2025 · Jun 30, 2025 −$1.13
Eps Basic Q2 2025 · Jun 30, 2024 −$3.31
Eps Basic Q2 2025 · Jun 30, 2024 −$7.67
Sga Expense Q2 2025 · Jun 30, 2025 $1.63M
Sga Expense Q2 2025 · Jun 30, 2025 $3.52M
Sga Expense Q2 2025 · Jun 30, 2024 $2.04M
Sga Expense Q2 2025 · Jun 30, 2024 $4.36M
Rd Expense Q2 2025 · Jun 30, 2025 $409.94K
Rd Expense Q2 2025 · Jun 30, 2025 $668.81K
Rd Expense Q2 2025 · Jun 30, 2024 $709.05K
Rd Expense Q2 2025 · Jun 30, 2024 $1.22M
Net Income Q2 2025 · Jun 30, 2025 −$2.21M
Net Income Q2 2025 · Jun 30, 2025 −$4.47M
Net Income Q2 2025 · Mar 31, 2025 −$2.26M
Net Income Q2 2025 · Jun 30, 2024 −$2.76M
Net Income Q2 2025 · Jun 30, 2024 −$5.59M
Net Income Q2 2025 · Mar 31, 2024 −$2.83M
Operating Income Q2 2025 · Jun 30, 2025 −$2.04M
Operating Income Q2 2025 · Jun 30, 2025 −$4.19M
Operating Income Q2 2025 · Jun 30, 2024 −$2.75M
Operating Income Q2 2025 · Jun 30, 2024 −$5.58M